Medications and therapy are two of the most common treatments for anxiety, and they're highly effective. But there are also ...

Trileptal (oxcarbazepine) is an anti-seizure drug sometimes taken off-label for bipolar disorder. Learn more about how it ...

Bipolar disorder, which can be diagnosed as either type 1 or type 2, affects approximately 40 million people worldwide, according to the World Heath Organization (WHO). Some common signs or symptoms ...

A team of researchers from the Chinese Academy of Sciences has uncovered compelling evidence of a genetic link between bipolar disorder type I (BD-I) and epilepsy, potentially revolutionizing our ...

And many patients who wind up with the label of bipolar disorder are initially misdiagnosed with unipolar depression. Misdiagnosed patients like Ola often look back on years of worsening symptoms and ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the ...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine ...

With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in ...

In an interview with The Guardian, Chappell Roan -- who has previously opened up about her struggles with bipolar II disorder ...

BioXcel Therapeutics (BTAI) stock gains as company shifts focus from commercial support for FDA-approved drug, Igalmi to lead ...